<DOC>
	<DOCNO>NCT01075256</DOCNO>
	<brief_summary>To evaluate efficacy two different concentration tubule occlusion agent - calcium sodium phosphosilicate treatment dentine hypersensitivity</brief_summary>
	<brief_title>Dose Response Tubule Occlusion Agent</brief_title>
	<detailed_description>Dentine hypersensitivity characterize short , sharp pain arise expose dentine typically response chemical , thermal , tactile osmotic stimulus . Dentine hypersensitivity may treat either make nerve tooth less sensitive occlude tubule limit exposure nerve external stimulus . Bioactive biocompatible glass react oral fluid deposit mineral chemically analogous find enamel dentine thus prevent exposure nerve external stimulus . A number control clinical trial report indicate calcium sodium phosphosilicate bioactive glass , incorporate toothpaste formulation , significantly reduce pain dentine hypersensitivity . The aim study evaluate effectiveness two currently market toothpaste , contain 5 % calcium sodium phosphosilicate contain 7.5 % calcium sodium phosphosilicate treatment dentine hypersensitivity compare matched placebo control .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Dentin Sensitivity</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>1 . Consent : Demonstrates understand study willingness participate evidence voluntary write informed consent receive sign date copy inform consent form . 2 . Age : Aged 20 50 year . 3 . General Health : Good general health ( opinion investigator ) clinically significant relevant abnormality medical history . 4 . Contraception : Females childbearing potential , opinion investigator , practise reliable method contraception . 5 . Erosion/Abrasion/Recession : Study teeth must show sign facial/cervical erosion , abrasion and/or gingival recession . 6 . Gingival Health / Tooth Mobility Grade : Study teeth must LÃ¶e Silness Gingival Index ( GI ) score less equal 2 clinical mobility less equal grade I . 7 . Current Product Use : Participants must use brand toothpaste least 2 month use desensitize toothpaste 4 week precede screen . Participants require bring current toothpaste ( ) order verify ingredient . 8 . VAS Training : Successfully complete VAS training exercise Screening . 9 . Sensitivity : Selfreported history dentinal hypersensitivity primary complaint sensitive teeth last maximum 10 year . At Screening : A minimum 5 evaporative ( air ) sensitive lateral incisor , canine premolar must display response great 25 mm 100 mm VAS . At Baseline : A minimum 3 5 evaporative ( air ) sensitive teeth identify screen must display response great 25 mm 100 mm VAS . All teeth meeting sensitivity Inclusion Criteria follow assess use efficacy parameter . 10 . Compliance : Understands willing , able likely comply study procedure restriction . 1 . Pregnancy : Women know pregnant intend become pregnant duration study . 2 . Breastfeeding : Women breastfeed . 3 . Medical History : ) Chronic debilitate disease present b ) Chronic disease condition present associate intermittent episode constant daily pain , arthritis , low back pain , dysmenorrhea , etc . 4 . Medications : Daily dos medication , opinion investigator , might interfere perception pain , take . Examples medication include analgesic , anticonvulsant , antihistamine cause mark moderate sedation , sedative , tranquilizer , moodaltering antiinflammatory drug . 5 . Dentition Exclusions : ) Sensitive teeth expect respond treatment overthe counter ( OTC ) dentifrice opinion investigator . b ) Teeth expose dentine deep , defective facial restoration , teeth use abutment fix removable partial denture , teeth full crown , orthodontic band , extensive caries crack enamel . Sensitive teeth contribute aetiology erosion , abrasion recession expose dentine . c ) Dental professional hygiene ( include dental prophylaxis , irrigation , intensive antimicrobial/antibiotic therapy ) within 14 day screen visit . ) Presence dental implant . e ) Lip tongue piercings . f ) Periodontal surgical history within past 6 month scale /root plan within past 3 month . 6 . Allergy/Intolerance : Known suspected intolerance hypersensitivity study material ( closely relate compound ) state ingredient . 7 . Clinical Study/Experimental Medication : ) Participation another clinical study receipt investigational drug within 30 day screen visit.b ) Previous participation study . 8 . Xerostomia : Any condition medication cause xerostomia . 9 . Personnel : An employee sponsor study site member immediate family . 10 . Other : Any subject opinion investigator , participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>sensitivity</keyword>
	<keyword>occlusion</keyword>
</DOC>